FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/07/090611 [Registered on: 09/07/2025] Trial Registered Prospectively
Last Modified On: 02/07/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A comparative clinical study of Chandanadi vati and Bala tail matra basti to manage excessive bleeding per vaginum 
Scientific Title of Study   A Comparative Clinical Study To Evaluate the Efficacy of Chandanadi vati And Bala Tail Matra Basti in the Management of Asrigdara W.S.R To Menorrahgia 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Sima Bharti 
Designation  MS Scholar (Prasuti Tantra Evum Stri Roga) 
Affiliation  State Ayurvedic College And Hospital Tulsidas marg Turiyaganj Lucknow 
Address  PG Department of Prasuti Tantra Evum Stri Roga State Ayurvedic College And Hospital Tulsidas marg Turiyaganj Lucknow Uttar Pradesh India

Lucknow
UTTAR PRADESH
226004
India 
Phone  9336525405  
Fax  0  
Email  dr.simamit@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Prof Shashi Sharma 
Designation  Professor & HOD 
Affiliation  State Ayurvedic College And Hospital Tulsidas marg Turiyaganj Lucknow 
Address  PG Department of Prasuti Tantra Evum Stri Roga State Ayurvedic College And Hospital Tulsidas marg Turiyaganj Lucknow Uttar Pradesh India

Lucknow
UTTAR PRADESH
226004
India 
Phone  8795545443  
Fax  0  
Email  shashi.chd98@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Sima Bharti 
Designation  MS Scholar(Prasuti Tantra Evum Stri Roga) 
Affiliation  State Ayurvedic College And Hospital Tulsidas marg Turiyaganj Lucknow 
Address  PG Department of Prasuti Tantra Evum Stri Roga State Ayurvedic College And Hospital Tulsidas marg Turiyaganj Lucknow Uttar Pradesh India

Lucknow
UTTAR PRADESH
226004
India 
Phone  09336525405  
Fax  0  
Email  dr.simamit@gmail.com  
 
Source of Monetary or Material Support  
State Ayurvedic College And Hospital Tulsidas Marg Turiyaganj Lucknow, Uttar Pradesh India 226004 
 
Primary Sponsor  
Name  State Ayurvedic College And Hospital Tulsidas Marg Turiyaganj Lucknow 
Address  PG Department of Prasuti Tantra Evum Stri Roga State Ayurvedic College And Hospital Tulsidas Marg Turiyaganj Lucknow, Uttar Pradesh India 226004 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL   
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sima Bharti  State Ayurvedic College and hospital Lucknow Uttar Pradesh India 226004  PG Department of Prasuti Tantra Evum Stri Roga State Ayurvedic College And Hospital Tulsidas marg Turiyaganj Lucknow Uttar Pradesh India 226004
Lucknow
UTTAR PRADESH 
09336525405
0
dr.simamit@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Office of Institutional Commitee State Ayurvedic College and Hospital Lucknow  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N921||Excessive and frequent menstruation with irregular cycle. Ayurveda Condition: ASRUGDARAH/RAKTAPRADARAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Chandanadi Vati, Reference: Bhaisajya Ratnavali 66/20-24, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 1000(mg), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 3 Months, anupAna/sahapAna: Yes(details: Tandulodak ), Additional Information: Bhaisajya ratnavali 66/20-24 is reference of chandanadi churna but here it will be used in the form of Vati with same content Dose 2 tab BD(500mg each)
2Comparator ArmDrugClassical(1) Medicine Name: Bala Taila Matra basti , Reference: Bhel Chikitsa 24/14-18, Route: Rectal, Dosage Form: Taila, Dose: 60(ml), Frequency: od, Bhaishajya Kal: Adhobhakta, Duration: 3 Months, anupAna/sahapAna: No, Additional Information: Per rectal for 7 days after clearance of menses
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  45.00 Year(s)
Gender  Female 
Details  1.Patient having excessive, prolonged and intermenstrul bleeding.
2.Patient with age group of 20-45 years.
3.Patient Hb % more than 10 gm 
 
ExclusionCriteria 
Details  1.Patient having uterine fibroid, uterine polyps, adenomyosis.
2.Malignant growth in uterus.
3.Patients considered having thyroid dysfunction, liver dysfunction, coagulation disorders etc.
4.Patient having systemic illness like diabetes, and hypertension etc.
5.Patient with IUCD and OCP.
6.Patient giving history of recent delivery or abortion. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
1.To evaluate the efficacy of Chandanadi Vati with Bala Tail matra basti in the management of Asrigdara w.s.r. To Menorrahgia.
2.To Compare the clinical efficacy of Chandanadi vati and Bala tail Matra basti in the management of Asrigdara w.s.r To Menorrhagia.  
1.at 4 weeks
2.at 4 weeks 
 
Secondary Outcome  
Outcome  TimePoints 
1.To study the critical review of ayurvedic & modern literature on Asrigdara w.s.r. To Menorrhagia.
2.To study the adverse effects of both the trial drug and procedure.
3. To find out safe, effective therapy that covers various clinical conditions of
Asrigdara.
4.Reduction in pain,Duration,and amount of menstrual bleeding. 
after 30days
after 30days
after 30days of trial 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   15/07/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This is a randomised, comperative clinical study phase 2 parallel group trial.Comparing the efficacy of chandanadi vati and bala tail matra basti for 3 months in 40 patients.the patient fulfilling clinical criteria for diagnosis of asrigdara(menorrhagia) will be randomly selected from OPD/IPD of Department of Prasuti  tantra evum stri roga State Ayurvedic College and Hospital Lucknow and reffered cases from other hospital.A carefully histoy physical examination and nessesary investigation will be performed. futher patient devided into 2 groups.
Group A -  20 Patients will be given the trial drug chandanadi vati 2BD (500mg each) will be given orally after meal  with Tandulodak from 5th day of menstrual cycle to 1st day of next menstrual cycle with Bala taila (30 -60 ml) matra basti anter clearance of menses fon 3 consecutive cycle.
Group B - 20 patients of this group will be given the trial drug Bala tail matra basti after clearance of menses for 3 consecutive cycles. 
Follow up - On the clearance of each mentrual cycle.
 
Close